MedPath

Preparation and Characterization Intranasal Film Loaded With Steroid as a Local Treatment of Anosmia in Compare to Insulin Intranasal Film

Phase 1
Completed
Conditions
Smell Loss
Interventions
Registration Number
NCT05328414
Lead Sponsor
Deraya University
Brief Summary

This study is a growing step of phase I study published on March 2021. The study was implicated on Minia university on small scale of patient (20) to investigate the impact of insulin as fast dissolving films for intranasal delivery to treat anosmia in post COVID-19 infections. this record will modify the first formulation by addition certain concentration of steroid.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • All patients' adults aged from 18 years to 50 will included in the study.
  • A confirmed case (positive PCR), recovered/discharged (2 negative PCR),
  • suffering from sudden recent anosmia or hyposmia with or without loss of taste.
Exclusion Criteria
  1. Patients with chronic sinusitis.
  2. Patients with acute allergic rhinitis.
  3. Patients' nasal polyposis
  4. Patients with history of nasal surgery, severe head trauma or any medical condition that may affect sense of smell.
  5. Patient poly morbidities or poly pharmacy.
  6. Elder, pregnant, or nursing woman.
  7. Patients with chronic diseases.
  8. Autoimmune diseases.
  9. Patient suffering end organ problems.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo groupPrednisolone-
steroid based intranasal filmPrednisolone-
Primary Outcome Measures
NameTimeMethod
Smell restoringthree week

Sniffs test; to recogonize the first concentration he could identify

Secondary Outcome Measures
NameTimeMethod
inflammationthree weeks

to measure the extent of inflammation the reddness and size

Trial Locations

Locations (1)

Soad A. Mohamad

🇪🇬

Minya, المنيا, Egypt

© Copyright 2025. All Rights Reserved by MedPath